NeuroPace, Inc. (NPCE) 은(는) 상장 기업입니다 헬스케어 섹터의 Medical - Devices 산업에서 운영. 본사 소재지는 Mountain View, CA, 미국. 현재 CEO는 Joel D. Becker.
NPCE 을(를) 보유 IPO 날짜 2021-04-22, 184 명의 정규직 직원, 에 상장 NASDAQ Global Market, 시가총액 $516.79M.
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.
